Elevance Health, Inc. (NYSE:ELV) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Elevance Health, Inc. (NYSE:ELV) have earned a consensus recommendation of “Moderate Buy” from the twenty-three brokerages that are presently covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $384.5789.

Several equities analysts have weighed in on ELV shares. Wall Street Zen cut Elevance Health from a “buy” rating to a “hold” rating in a report on Sunday, February 8th. Barclays upped their price objective on Elevance Health from $393.00 to $408.00 and gave the stock an “overweight” rating in a report on Friday, April 24th. Weiss Ratings raised shares of Elevance Health from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, April 24th. Jefferies Financial Group reduced their price target on shares of Elevance Health from $395.00 to $391.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Finally, Royal Bank Of Canada downgraded shares of Elevance Health from an “outperform” rating to a “sector perform” rating and set a $358.00 price target on the stock. in a research note on Tuesday, February 3rd.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ELV. Physician Wealth Advisors Inc. lifted its stake in shares of Elevance Health by 331.6% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock valued at $26,000 after purchasing an additional 63 shares during the last quarter. Rossby Financial LCC increased its position in shares of Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company’s stock valued at $28,000 after purchasing an additional 44 shares during the last quarter. Activest Wealth Management raised its holdings in Elevance Health by 66.7% during the 3rd quarter. Activest Wealth Management now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 34 shares during the period. Kemnay Advisory Services Inc. purchased a new position in Elevance Health during the fourth quarter worth $31,000. Finally, J.Safra Asset Management Corp purchased a new position in Elevance Health during the fourth quarter worth $32,000. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Elevance Health Stock Down 1.0%

Shares of ELV stock opened at $392.74 on Friday. The company’s fifty day simple moving average is $322.88 and its two-hundred day simple moving average is $334.02. Elevance Health has a 52 week low of $273.71 and a 52 week high of $412.96. The stock has a market cap of $85.29 billion, a P/E ratio of 16.71, a PEG ratio of 2.26 and a beta of 0.66. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.70.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 earnings per share for the quarter, beating analysts’ consensus estimates of $10.74 by $1.84. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The firm had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. During the same quarter last year, the business posted $11.97 earnings per share. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Analysts predict that Elevance Health will post 26.79 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Wednesday, June 10th will be issued a $1.72 dividend. The ex-dividend date is Wednesday, June 10th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.8%. Elevance Health’s payout ratio is 29.26%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.